Trust architecture

Show what is known, what is uncertain, and what was actually verified.

The editorial system separates guideline support, regulatory labeling, clinical evidence, adoption, access, provider confirmation, and commercial relationships.

Evidence reviewed August 14, 2026Clinical review pending; evidence sources are shown

Evidence hierarchy

Current professional guidelines and official regulatory records anchor the treatment model. Randomized trials, prospective cohorts, systematic reviews, and long-term follow-up add procedure-specific detail. Manufacturer material may identify a device or provider capability but is not treated as independent efficacy evidence.

Separate maturity dimensions

The site does not compress evidence, regulatory status, adoption, access, recovery, or durability into one score. A newly approved option can be legitimate but access-limited and supported by shorter follow-up. An established option can be widely available but carry a tradeoff a patient strongly dislikes.

Medical review

No page is labeled medically reviewed unless a named qualified reviewer has reviewed the exact version and the review is recorded. Until then, the visible status says that clinical review is pending and provides the source trail.

Corrections and updates

Core pages carry an evidence-review date. Regulatory changes, major guideline updates, safety notices, or device withdrawals trigger earlier review. Provider capabilities have their own verification and expiration dates.

Commercial independence

Payment is kept in a separate data model. Sponsored placements must be labeled. Commercial relationships cannot create a verification badge, alter evidence wording, or silently change organic clinical ordering.

Privacy posture

The navigator computes results on the device and does not store answers. Ordinary analytics, when enabled, should capture broad page and feature events—not symptom answers, diagnoses, free text, records, or exact treatment candidacy inputs.

Content language rules

  • Use plain language without erasing meaningful uncertainty.
  • Avoid “best,” “perfect candidate,” “revolutionary,” and “minimally invasive means easy.”
  • Distinguish symptom improvement, flow improvement, and retreatment durability.
  • Distinguish erections, ejaculation, orgasm, semen volume, and fertility.
  • State anatomy and technique boundaries rather than generalizing a device label.
  • Describe what happens if treatment fails or only partly works.
Review the source library